Psychiatric wandering behaviour in dementia patients correlated with increased striatal dopamine D2 receptor as shown by [11C]YM-09151-2 and positron emission tomography

European Journal of Neurology

Volumn 4, Issue 3, 1997, Pages 221-226

  Meguro, K ^a   Itoh, M ^b   Yanai, K ^c   Takase, K ^b   Yamaguchi, S ^a   Ido, T ^b   Yamadori, A ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Positron emission tomography; Wandering behaviour

Indexed keywords

DOPAMINE 2 RECEPTOR; EMONAPRIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BRAIN FUNCTION; CALCULATION; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; HUMAN; ISOTOPE LABELING; MULTIINFARCT DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RECEPTOR BINDING; STATISTICAL ANALYSIS;

EID: 0030858898     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1997.tb00338.x     Document Type: Article

References (38)

1. Albert MS, Feldman RG and Willis AL (1974) The "subcortical dementia" of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry, 37, 121-130.
2. Bliwize DL (1993) Sleep in normal aging and dementia. Sleep, 16, 40-81.
3. 11C-raclopride and positron emission tomography. Annals of Neurology, 31, 184-192.
4. Burns A, Jacoby R and Levy R (1990) Psychiatric phenomena in Alzheimer's disease. IV. Disorders of Behaviour. British Journal of Psychiatry, 157, 86-94.
5. Cummings JL and Victoroff JI (1990) Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry, Neuropsychology and Behavioural Neurology, 3, 140-158.
6. 2 dopamine receptor binding in the living human brain by PET. Science, 231, 258-261.
7. Folstein MS, Folstein SF and McHugh PR (1975) "Mini-mental state", a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12, 189-198.
8. Garnett ES, Firnau G and Nahmias C (1983) Dopamine visualized in the basal ganglia of living man. Nature, 305, 137-138.
9. 2-dopamine receptor-specific brain uptake of carbon-11-labeled YM-09151-2. Journal of Nuclear Medicine, 30, 515-522.
10. Hatazawa J, Hatano K, Ishiwata K, Itoh M, Ido T, Kawashima K, Meguro K, Watanuki S and Seo S (1991) Measurement of D2-dopamine receptor-specific carbon-11-YM-09151-2 binding in the canine brain by PET: importance of partial volume correction. Journal of Nuclear Medicine 32, 713-718.
11. Huang SC, Barrio JR and Phelps ME (1986) Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. Journal of Cerebral Blood Flow and Metabolism, 6, 515-521.
12. 1 antagonist. European Journal of Pharmacology, 91, 153-154.
13. 18F-fluorodopa and PET. Annals of Nuclear Medicine, 8(4), 245-251.
14. Itoh M, Yamaguchi, S, Meguro K, Fujiwara, R, Iwata R, Ido T and Sasaki H (1995) Neuroreceptor PET: assessment of dopamine neurotransmission in dementia. In: Brain, Heart and Tumor Imaging. Updated PET and MRI (Ed. H Ochi et al.) Oxford, Elsevier.
15. Leenders KL, Herold S, Brooks DJ, Palmer AJ, Turton D, Firnau G, Garnett ES, Nahmias C and Veall N (1984) Presynaptic and postsynaptic dopaminergic system in human brain. Lancet, 14, 110-111.
16. Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, Nahmias C, Jones T and Marsden CD (1986) Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. Journal of Neurology, Neurosurgery and Psychiatry, 49, 853-860.
17. Majovski LV, Jacques S, Hartz G and Fogwell LA (1981) Dopaminergic (DA) systems: their role in pathological neurobehavioural symptoms. Neurosurgery, 9(6), 751-757.
18. McKhann G, Drachman D and Flostein M (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology, 34, 939-944.
19. Meguro K, Ueda M, Yamaguchi T, Sekita Y, Yamazaki H, Oikawa Y, Kikuchi Y and Matsuzawa T (1990) Disturbance in daily sleep/wake patterns in patients with cognitive impairment and decreased daily activity. Journal of the American Geriatric Society, 38, 1176-1182.
20. Meguro K, Oikawa Y, Kikuchi Y, Yamazaki H nd Sasaki H (1991) The effect of thiapride hydrochloride on senile dementia. Geriatric Medicine (Japan), 29(2), 325-335.
21. Meguro K, Yamaguchi S, Yamazaki H, Itoh M, Yamaguchi T, Matsui H and Sasaki H (1996) Cortical glucose metabolism in psychiatric wandering patients with vascular dementia. Psychiatry Research: Neuroimaging, 67, 71-80.
22. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF and Welch M (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Annals of Neurology, 15, 217-227.
23. Moore RY and Eichler VB (1972) Loss of a circadian adrenal corticosterone rhythm following suprachiasmtic lesions in the rat. Brain Research, 42, 201-206.
24. Myers RE, Swett C and Miller M (1973) Loss of social group affinity following prefrontal lesions in free-ranging macaques. Brain Research, 64, 201-206.
25. Nahmias C, Garnett ES, Firnau G and Lang A (1985) Striatal dopamine distribution in parkinsonian patients during life. Journal of Neurological Sciences, 69, 223-230.
26. Patlak CS, Blasberg RG and Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Journal of Cerebral Blood Flow and Metabolism, 3, 1-7.
27. Perlmutter JS, Larson KB, Raichle ME, Markham J, Mintun MA, Kilbourn MR and Welch MJ (1986) Strategics for in vivo measurement of receptor binding using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 6, 154-159.
28. 2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Movement Disorders, 5(1), 55-59.
29. Roman GC, Takemichi TK and Erkinjuntti (1992) Vascular dementia: diagnostic criteria for research studies, report of the NINDS-AIREN international workshops. Neurology, 43, 250-260.
30. Stephan FK and Zucker I (1972) Circadian rhythms in drinking behaviour and locomotor activity of rats are eliminated by hypothalamic lesions. Proceedings in Natural Academic Science of USA, 69, 1566-1583.
31. Suhara T, Fukuda H, Inoue O, Itoh T, Suzuki K, Yamasaki T and Tateno Y (1991) Age-related changes in human D, dopamine receptors measured by positron emission tomography. Psychopharmacology, 103, 41-45.
32. Sultzer DL, Levin HS, Mahler ME, Walter M and Cummings JL (1992) Assessment of cognitive, psychiatric and behavioural disturbances in patients with dementia: the Neurobehavioural Rating Scale. Journal of the American Geriatric Society, 40, 549-555.
33. Swaab DF, Fliers E and Partiman TS (1985) The suprachiasmatic nucleus of the human brain in relatin to sex, age and senile dementia. Brain Research, 342, 37-45.
34. 2-dopaminergic receptors. Japanese Journal of Pharmacology, 33, 749-755.
35. Teri L, Larson EB and Reifler BV (1988) Behavioral disturbance in dementia of the Alzheimer's type. Journal of the American Geriatric Society, 36, 1-6.
36. Vitiello MV, Bliwize DL and Prinz PN (1992) Sleep in Alzheimer's disease and the sundown syndrome. Neurology, 42(Suppl. 6), 83-94.
37. Willner P, Aghlenius S, Muscat R and Scheel-Kruger J (1991) The mesolimbic dopamine system. In: The Mesolimbic Dopamine System: From Motivation to Action (Ed. P Willner and J Scheel-Kruger). Chichester, Wiley.
38. Wong DF, Wagner Jr HN, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglass KH, Petronis JD, Folstein MF, Toung JKT, Burns HD and Kuhar MJ (1984) Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living humn brain. Science, 226, 1393-1396.